142 related articles for article (PubMed ID: 19569246)
1. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
Chamberlain MC; Johnston SK
Cancer; 2009 Oct; 115(20):4775-82. PubMed ID: 19569246
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide for recurrent low-grade spinal cord gliomas in adults.
Chamberlain MC
Cancer; 2008 Sep; 113(5):1019-24. PubMed ID: 18615600
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
Rudà R; Bosa C; Magistrello M; Franchino F; Pellerino A; Fiano V; Trevisan M; Cassoni P; Soffietti R
Neuro Oncol; 2016 Feb; 18(2):261-8. PubMed ID: 26323606
[TBL] [Abstract][Full Text] [Related]
4. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
Chamberlain MC; Tsao-Wei DD
Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
[TBL] [Abstract][Full Text] [Related]
5. Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma.
Chamberlain MC; Tsao-Wei DD; Groshen S
Cancer; 2006 Jan; 106(1):172-9. PubMed ID: 16323194
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma.
Chamberlain MC; Johnston S
Cancer; 2009 Apr; 115(8):1734-43. PubMed ID: 19197992
[TBL] [Abstract][Full Text] [Related]
7. Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
Chamberlain MC
J Neurooncol; 2015 Apr; 122(2):329-38. PubMed ID: 25563816
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide for treatment-resistant recurrent meningioma.
Chamberlain MC; Tsao-Wei DD; Groshen S
Neurology; 2004 Apr; 62(7):1210-2. PubMed ID: 15079029
[TBL] [Abstract][Full Text] [Related]
9. Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma.
Chamberlain MC; Johnston S
J Neurooncol; 2009 Feb; 91(3):359-67. PubMed ID: 18953491
[TBL] [Abstract][Full Text] [Related]
10. CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma.
Chamberlain MC; Glantz MJ
J Neurooncol; 2008 Sep; 89(2):231-8. PubMed ID: 18480965
[TBL] [Abstract][Full Text] [Related]
11. Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma.
Chamberlain MC; Wei-Tsao DD; Blumenthal DT; Glantz MJ
Cancer; 2008 May; 112(9):2038-45. PubMed ID: 18361434
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
[TBL] [Abstract][Full Text] [Related]
13. Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma.
Freyschlag CF; Tuettenberg J; Lohr F; Thomé C; Schmieder K; Seiz M
Anticancer Res; 2011 Mar; 31(3):1023-5. PubMed ID: 21498732
[TBL] [Abstract][Full Text] [Related]
14. Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
Chamberlain MC; Colman H; Kim BT; Raizer J
J Neurooncol; 2017 Feb; 131(3):507-516. PubMed ID: 28204914
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study.
Jaeckle KA; Hess KR; Yung WK; Greenberg H; Fine H; Schiff D; Pollack IF; Kuhn J; Fink K; Mehta M; Cloughesy T; Nicholas MK; Chang S; Prados M;
J Clin Oncol; 2003 Jun; 21(12):2305-11. PubMed ID: 12805331
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium.
Everaert E; Neyns B; Joosens E; Strauven T; Branle F; Menten J
J Neurooncol; 2004 Oct; 70(1):37-48. PubMed ID: 15527106
[TBL] [Abstract][Full Text] [Related]
17. First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia.
Brandes AA; Basso U; Reni M; Vastola F; Tosoni A; Cavallo G; Scopece L; Ferreri AJ; Panucci MG; Monfardini S; Ermani M;
J Clin Oncol; 2004 May; 22(9):1598-604. PubMed ID: 15117981
[TBL] [Abstract][Full Text] [Related]
18. "One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.
Galldiks N; Berhorn T; Blau T; Dunkl V; Fink GR; Schroeter M
J Neurooncol; 2013 Apr; 112(2):209-15. PubMed ID: 23299464
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for intracranial ependymoma in adults.
Gramatzki D; Roth P; Felsberg J; Hofer S; Rushing EJ; Hentschel B; Westphal M; Krex D; Simon M; Schnell O; Wick W; Reifenberger G; Weller M
BMC Cancer; 2016 Apr; 16():287. PubMed ID: 27108407
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
